ERBB2 and non-small cell lung carcinoma: Human epidermal growth factor receptor 2 (HER2) is an actionable oncogenic driver in a small subset of non-small cell lung cancer (NSCLC), occurring as gene mutations and less frequently as gene amplification or protein overexpression.